Search Within

Adam D Cohen

Formats
  1. Meeting Abstract (22)
  2. Journal Article (19)
  3. Book Section (2)
  4. Book Whole (1)
Groups
  1. Department of Medicine (44)
  2. Hematologic Malignancies, Division of (35)
  3. Center for Hematologic Malignancies (28)
  4. Department of Pathology and Laboratory Medicine (21)
  5. Solid Tumor Oncology Division (21)
  6. GSK Faculty (20)

More Groups

People
  1. Raymond Comenzo (21)
  2. Jedd Wolchok (19)
  3. Hani Hassoun (16)
  4. Alan Houghton (15)
  5. Stephen Nimer (15)
  6. Martin Fleisher (13)

More People

Years
  1. 2021 (1)
  2. 2018 (1)
  3. 2013 (1)
  4. 2011 (1)
  5. 2010 (1)
  6. 2009 (4)

More Years

Publications
  1. Blood (14)
  2. Cancer Research (5)
  3. British Journal of Haematology (4)
  4. Journal of Clinical Oncology (3)
  5. PLoS ONE (3)
  6. Amyloid (1)

More Publications

Publishers
  1. American Society of Hematology (14)
  2. American Association for Cancer Research (5)
  3. John Wiley & Sons (4)
  4. American Society of Clinical Oncology (3)
  5. Elsevier Inc. (3)
  6. Public Library of Science (3)

More Publishers

Results (44)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hematology and oncology pearls
    Book Whole


    Mosby Elsevier (2005)

    Fulltext@MSK | Save
  • An agonist anti-GITR antibodyenhances effector and memory CD8 T cell responses and tumor immunity following xenogeneic DNA immunization against melanoma
    Meeting Abstract

    Cohen, A. D.; Diab, A.; Angel-Perales, M.; Wolchok, J. D.; Huggins, D.; Liu, C.; Turk, M. J.; Sakaguchi, S.; Houghton, A. N.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • The serum free light chain ratio after one or two cycles of treatment is highly predictive of the magnitude of final response in patients undergoing initial treatment for multiple myeloma
    Meeting Abstract

    Hassoun, H.; Reich, L.; Klimek, V. M.; Dhodapkar, M.; Cohen, A.; Kewalramani, T.; Riedel, E. R.; Hedvat, C. V.; Teruya-Feldstein, J.; Filippa, D. A.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Risk-adapted dosing of melphalan for systemic AL amyloidosis (AL) lowers treatment-related mortality: Early death but not post-3 month survival is linked to cardiac involvement
    Meeting Abstract

    Comenzo, R. L.; Zhou, P.; Hassoun, H.; Kewalramani, T.; Klimek, V.; Cohen, A. D.; Ferrand, S. K.; Dhodapkar, M.; Feldstein, J. T.; Fleisher, M.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Adjuvant dexamethasone (D)+/- thalidomide (T) improves hematologic and organ responses after risk-adapted high-dose melphalan with autologous stem cell transplant (SCT) for patients with systemic AL amyloidosis (AL)
    Meeting Abstract

    Cohen, A. D.; Zhou, P.; Reich, L.; Hassoun, H.; Teruya-Feldstein, J.; Filippa, D. A.; Fleisher, M.; Nimer, S. D.; Comenzo, R. L.
    Blood (2005)

    Fulltext@MSK | Save
  • Interim analysis of a phase II study of risk-adapted intravenous melphalan followed by adjuvant dexamethasone (D) and thalidomide (T) for newly diagnosed patients with systemic AL amyloidosis (AL)
    Meeting Abstract

    Cohen, A. D.; Zhou, P.; Reich, L.; Fircanis, S.; Drake, L.; Hedvat, C.; Teruya-Feldstein, J.; Filippa, D. A.; Fleisher, M.; Comenzo, R. L.
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • IL-15: Targeting CD8 + T cells for immunotherapy
    Journal Article

    Diab, A.; Cohen, A. D.; Alpdogan, O.; Perales, M. A.
    Cytotherapy (2005)

    Fulltext@MSK | Save
  • DNA vaccines for melanoma
    Journal Article

    Cohen, A. D.; Wolchok, J. D.
    Cancer Chemotherapy and Biological Response Modifiers (2005)

    Fulltext@MSK | Save
  • DNA immunization against melanoma antigens enhances tumor immunity in mouse models of allogeneic hematopoietic stem cell transplantation (HSCT)
    Meeting Abstract

    Diab, A.; Perales, M. A.; Cohen, A.; Hubbard, V. M.; Eng, J.; Huggins, D.; Engelhorn, M.; Guevara, J. A; Alpdogan, O.; Wolchok, J. D.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • DNA immunization against melanoma antigens enhances tumor immunity in mice following sub-lethal irradiation and immune reconstitution
    Meeting Abstract

    Diab, A.; Hubbard, V. M.; Cohen, A.; Huggins, D.; Kochman, A.; Guevara, J. A; Engelhorn, M.; Wolchok, J. D.; Van Den Brink, M.; Houghton, A. N.; more...
    Blood (2004)

    Fulltext@MSK | Save